P95 Acquires 4Clinics to Expand Global CRO Services
July 1, 2024
P95 BV, an Ampersand Capital Partners portfolio company, has acquired 4Clinics, a contract research organization providing data management, biostatistics, medical writing, regulatory affairs and clinical operations. The acquisition (effective July 1, 2024) integrates 4Clinics' team into the P95 group to strengthen CRO capabilities—particularly in biometrics and medical writing—and to enhance service coverage for Francophone clients.
- Buyers
- P95 BV, Ampersand Capital Partners
- Targets
- 4Clinics
- Platforms
- P95 BV
- Industry
- Healthcare Services
- Location
- Belgium
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.